Healthcare Industry News: brachytherapy
News Release - April 28, 2008
Nucletron Announces Oncentra(R) Brachy* Treatment Planning Solution for Multimodality EnvironmentNew Anatomy-Based Solution for HDR/PDR brachytherapy Represents the Next Generation in DICOM-Compatible, Integrated Cancer Treatment Planning
VEENENDAAL, The Netherlands, April 28 (HSMN NewsFeed) -- Nucletron, a knowledge-based leader in radiation oncology, today announced the introduction of Oncentra® Brachy*, a comprehensive volume-based treatment planning system to optimize cancer treatment planning with brachytherapy. Oncentra Brachy, the world's first fully DICOM-compatible treatment planning system, features state-of-the-art optimization algorithms to ensure efficient treatment. The new solution provides excellent 3D contouring and margining tools to identify Regions of Interests (ROIs) on CT or in a multimodality imaging environments using image registration for CT, MR and PET data.
Oncentra Brachy provides many benefits to clinicians allowing for faster and easier creation of treatment plans, ranging from simple to complex, in user-defined workspaces that allow for adaptation to specific clinical workflows. Real-time information-sharing provides immediate access for the entire medical team and facilitates the exchange of treatment plans over vast distances with decentralized planning capabilities. Physicians are able to evaluate and authorize treatment plans remotely.
"The release of Oncentra Brachy marks the first of some new and exciting treatment planning innovations forthcoming from Nucletron," said Jeroen Cammeraat, chief operating officer of Nucletron. "We have set a new benchmark in technological achievement with Oncentra Brachy that represents the future of brachytherapy treatment planning. We have worked with our clinical partners to develop a state-of-the art solution that includes many sophisticated and powerful new tools to improve patient care."
"Oncentra Brachy opens new possibilities to explore new treatment techniques for brachytherapy planning that could not be considered before," according to the radiation oncology department of the Academic Medical Center (AMC) in Amsterdam. "As reconstruction and planning on MR data becomes reality, the user-friendliness of the system provides clinicians and physicists all the flexibility they need. We are able to create optimal and accurate plans to yield better treatment for our patients."
Oncentra Brachy is a part of fully integrated solution for brachytherapy treatment of a wide variety of cancers, giving medical professionals the most advanced systems to optimally treat patients using brachytherapy.
"As one of the original gamma testing sites for Oncentra Brachy, I am very pleased with the efficient and flexible tools of this new treatment planning system from Nucletron," said I-Chow Hsu, M.D., University of California San Francisco. "After testing the system thoroughly, we are planning to use Oncentra Brachy exclusively in our center."
Nucletron will have Oncentra Brachy on display at the 2008 World Congress of brachytherapy in Boston, MA , May 4-6 , Booth # 120.
* Regulatory clearance in North America is pending.
Nucletron is a knowledge-based leader in Radiation Oncology, working with clinical teams to realize innovative solutions that improve patient care. Nucletron strives to offer the best possible choice of radiation modalities through integrated products, software and services. Critical to the Nucletron philosophy is the establishment of close working relationships with individual clinical teams - reconfiguring traditional boundaries between customer and solution provider. Many Nucletron employees have clinical experience delivering oncology care, providing an in-depth understanding of the complex needs of clinicians. For more information, visit http://www.nucletron.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.